Influence of data disclosures on physician decisions about off-label uses: findings from a qualitative study

BACKGROUND: Prescribing approved products for unapproved uses (off-label use) is not uncommon among physicians in certain medical specialties. Available evidence about an off-label use – both supportive and unsupportive – can influence prescribers’ decisions about a drug’s appropriateness for a part...

Descripción completa

Detalles Bibliográficos
Autores principales: Chansky, Melanie C., Price, Simani M., Aikin, Kathryn J., O’Donoghue, Amie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017050/
https://www.ncbi.nlm.nih.gov/pubmed/35439962
http://dx.doi.org/10.1186/s12875-022-01666-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017050/
https://www.ncbi.nlm.nih.gov/pubmed/35439962
http://dx.doi.org/10.1186/s12875-022-01666-2

Ejemplares similares